AwardTape · Defense awards · Research and development · Health R&D · W81XWH21C0103
W81XWH21C0103: $0 definitive contract to Oculogica Inc
Oculogica Inc holds a definitive contract from Defense Health Agency with $0 obligated since Oct 2023 and $2.0M obligated over its life, against a ceiling of $2.0M. Latest action Jul 1, 2025.
Research and development proposal titled a highly portable device for assessment of mild traumatic brain injury in deployed and far-forward settings from broad agency announcement on behalf of congressionally directed medical research ...
| PIID | W81XWH21C0103 |
|---|---|
| Type | definitive contract |
| Company | Oculogica Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $2.0M |
| Ceiling (base and all options) | $2.0M |
| Base date | Sep 27, 2021 |
| Latest action | Jul 1, 2025 |
| End date | Dec 26, 2026 |
| Actions since Oct 2023 | 3 |
| Pricing | Fixed price level of effort |
| Competition | Full and open competition |
| Place of performance | WI |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial